Investing in a trusted partner to the world’s leading diagnostic and healthcare organisations
Deal size, November 2015 & June 2020
Funds III & IV
BBI Group offers a portfolio of products and services that are delivered to the diagnostic and life sciences industries globally. The business has sites in seven countries and four continents. A global team of over 500 experts provides critical reagents and immunoassay development and manufacturing services to a blue chip customer base that includes Thermo-Fisher, Merck and Siemens.
The company was acquired from Alere, a US publicly-listed healthcare business. Exponent worked alongside our Operating Chairperson Alan Peterson, to build the buy-out plan with BBI’s management team.
During our ownership, BBI has expanded its presence in the US, built operations in China, successfully completed three acquisitions and invested in a centre of excellence at its HQ in Crumlin, Wales.